Role of well-being therapy in achieving a balanced and individualized path to optimal functioning

Clinical Psychology & Psychotherapy
Chiara Ruini, G A Fava

Abstract

A specific psychotherapeutic strategy for increasing psychological well-being and resilience, well-being therapy (WBT), based on Ryff's conceptual model, has been developed and tested in a number of randomized controlled trials. The findings indicate that flourishing and resilience can be promoted by specific interventions leading to a positive evaluation of one's self, a sense of continued growth and development, the belief that life is purposeful and meaningful, the possession of quality relations with others, the capacity to manage effectively one's life and a sense of self-determination. A decreased vulnerability to depression, mood swings and anxiety has been demonstrated after WBT in high-risk populations. School interventions based on the principles of WBT have been found to yield both promotion of well-being and decrease of distress compared with control groups. The differential technical characteristics and indications of WBT are described, with a special reference to the promotion of an individualized and balanced path to achieve optimal human functioning, avoiding the polarities in positive psychological dimensions.

References

Jan 1, 1987·Journal of Psychosomatic Research·G Mendelson
Jul 1, 1985·Journal of Affective Disorders·E S Paykel
Sep 1, 1974·Behaviour Research and Therapy·P M Emmelkamp
Jan 1, 1996·Psychotherapy and Psychosomatics·C D Ryff, B Singer
Sep 15, 1998·Archives of General Psychiatry·G A FavaP Belluardo
Jul 9, 1999·Psychotherapy and Psychosomatics·G A Fava
Jul 14, 1999·Behaviour Research and Therapy·J E Gillham, M E Seligman
Jul 19, 2001·Psychological Medicine·G A FavaP Belluardo
Apr 6, 2002·Psychological Science·Barbara L Fredrickson, Thomas Joiner
May 22, 2002·Psychosomatic Medicine·Teresa E SeemanLené Levy-Storms
Jul 5, 2002·Journal of Health and Social Behavior·Corey L M Keyes
Sep 5, 2002·Journal of Clinical Psychology·Barbara S Held
Sep 5, 2002·Journal of Clinical Psychology·Julie K Norem, Edward C Chang
Sep 5, 2002·Journal of Clinical Psychology·Arthur C Bohart
Nov 27, 2002·The American Journal of Psychiatry·Giovanni A FavaSilvana Grandi
Feb 15, 2003·Journal of Personality and Social Psychology·Robert A Emmons, Michael E McCullough
May 24, 2003·Journal of Behavior Therapy and Experimental Psychiatry·Giovanni A Fava, Chiara Ruini
Jul 5, 2003·Journal of Psychiatric Research·Nicoletta Sonino, Giovanni A Fava
Nov 1, 1954·The American Journal of Psychiatry·M B PARLOFFJ D FRANK
Jan 1, 1961·The Psychiatric Quarterly·N J LEVY
Jan 1, 1960·IRE Transactions on Medical Electronics·G L ENGEL
Jan 1, 1960·Perspectives in Biology and Medicine·G L ENGEL
Oct 17, 2003·Journal of Personality and Social Psychology·Robert J VallerandJosee Marsolais
Oct 7, 2004·The American Journal of Psychiatry·Giovanni A FavaSilvana Grandi
Jan 4, 2005·Psychotherapy and Psychosomatics·Giovanni A FavaSaulo Sirigatti
Jun 11, 2005·Psychotherapy and Psychosomatics·Carlotta BelaiseIsaac M Marks
Jul 28, 2005·The American Psychologist·Martin E P SeligmanChristopher Peterson
Oct 14, 2005·The American Psychologist·Barbara L Fredrickson, Marcial F Losada
Jan 20, 2006·The Journal of Clinical Psychiatry·Giovanni A FavaChiara Rafanelli
Oct 21, 2006·Psychotherapy and Psychosomatics·Chiara RuiniGiovanni A Fava
Nov 23, 2006·The American Psychologist·Martin E P SeligmanAcacia C Parks
Jan 9, 2007·Journal of Behavior Therapy and Experimental Psychiatry·Peter MurisRobert Horselenberg
Feb 22, 2007·Psychological Medicine·Giovanni A FavaCarlotta Belaise
May 11, 2007·Journal of Personality·Robert J VallerandCéline Blanchard
Aug 19, 2007·Psychotherapy and Psychosomatics·Giovanni A FavaSilvana Grandi
Mar 19, 2009·Journal of Clinical Psychology·Tayyab Rashid
Mar 19, 2009·Journal of Clinical Psychology·Robert Biswas-Diener
Jun 23, 2009·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Vera RomanoMarilyn R Fitzpatrick
Aug 18, 2009·Journal of Behavior Therapy and Experimental Psychiatry·Chiara RuiniGiovanni A Fava
Sep 10, 2009·Psychotherapy and Psychosomatics·Elisa AlbieriChiara Ruini

❮ Previous
Next ❯

Citations

Nov 5, 2014·Proceedings of the National Academy of Sciences of the United States of America·Eric S KimCarol D Ryff
Mar 13, 2014·Explore : the Journal of Science and Healing·Chiara Ruini, Fedra Ottolini
Jul 22, 2014·Clinical Psychology & Psychotherapy·Olivia J H Edmondson, Andrew K MacLeod
Nov 26, 2015·European Eating Disorders Review : the Journal of the Eating Disorders Association·Federico AmiantoSecondo Fassino
Mar 31, 2015·Journal of Behavioral Medicine·Eric S KimVictor J Strecher
Nov 29, 2014·The Journal of Positive Psychology·Mathew A White, Lea E Waters
Aug 5, 2017·Clinical Psychology & Psychotherapy·Martina BrandelChiara Ruini
Jan 11, 2020·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Andrew MacLeod
Aug 15, 2020·Epidemiology and Psychiatric Sciences·Laura D KubzanskyMartin E P Seligman
Oct 24, 2017·International Review of Economics·Carol D Ryff
Mar 9, 2018·Journal of Reproductive and Infant Psychology·Marta BassiChiara Ruini
Oct 31, 2019·American Journal of Lifestyle Medicine·Garry EggerBob Morgan
Nov 20, 2020·International Journal of Environmental Research and Public Health·Guadalupe EcheverríaAttilio Rigotti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.